An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT00440557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open Label, Multicenter Study of Epoetin Alfa Comparing Two Extended-Dosing Regimens, Once-Weekly and Every-Two-Weeks, With the Three-Times-Weekly Dosing Regimen for Initiation and Maintenance Treatment in Anemic Subjects With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate that once weekly and once every-2-weeks treatment with epoetin alfa, in patients with anemia associated with chronic kidney disease, is not less effective than the approved treatment with epoetin alfa that is given 3 times weekly with respect to changes in hemoglobin.
Study identification
- NCT ID
- NCT00440557
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 375 participants
Conditions and interventions
Conditions
Interventions
- Epoetin alfa 3 times weekly /once weekly Drug
- Epoetin alfa once weekly Drug
- Epoetin alfa once every two weeks Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2006 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Feb 2008 (Actual)
- Last update posted
- May 7, 2014
2006 – 2008
United States locations
- U.S. sites
- 61
- U.S. states
- 20
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Glendale | Arizona | — | — |
| Not listed | Tempe | Arizona | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Lynwood | California | — | — |
| Not listed | Riverside | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Visalia | California | — | — |
| Not listed | Whittier | California | — | — |
| Not listed | Yuba City | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Lakewood | Colorado | — | — |
| Not listed | Thornton | Colorado | — | — |
| Not listed | Lauderdale Lakes | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Palm Beach Gardens | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Zephyrhills | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Carrollton | Georgia | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Statesboro | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Peoria | Illinois | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Bethesda | Maryland | — | — |
| Not listed | Methuen | Massachusetts | — | — |
| Not listed | Plymouth | Massachusetts | — | — |
| Not listed | Flint | Michigan | — | — |
| Not listed | Hackensack | New Jersey | — | — |
| Not listed | Old Bridge | New Jersey | — | — |
| Not listed | Vineland | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Great Neck | New York | — | — |
| Not listed | New Hartford | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | Springfield Gardens | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Greenville | North Carolina | — | — |
| Not listed | Maumee | Ohio | — | — |
| Not listed | Doylestown | Pennsylvania | — | — |
| Not listed | Easton | Pennsylvania | — | — |
| Not listed | Erie | Pennsylvania | — | — |
| Not listed | Lancaster | Pennsylvania | — | — |
| Not listed | Wynnewood | Pennsylvania | — | — |
| Not listed | Bamberg | South Carolina | — | — |
| Not listed | Orangeburg | South Carolina | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Dyersburg | Tennessee | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Chesapeake | Virginia | — | — |
| Not listed | Fairfax | Virginia | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00440557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2014 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00440557 live on ClinicalTrials.gov.